Dr. Peter McDonnell, Global Innovation Strategy & External Partnerships Manager, SANOFI & Technical Director, Genzyme
Peter McDonnell started as an organic chemist and has worked in academia, for Wellcome, Parke-Davis, Genzyme and latterly Sanofi. He has over 30 years of experience in the pharmaceutical industry in medicinal chemistry, development chemistry, formulation development and biotechnology and is currently Global Innovation Strategy and External Partnerships Manager for Sanofi, based in Paris.
Dr. András Ballagi, Head of the Pharmatech Model Laboratory - Biotech Unit at the Budapest University of Technology and Economics & Scientific Advisor at Gedeon Richter
Dr. Andras Ballagi is a Scientific Advisor at the Gedeon Richter Pharmaceutical Company and the Head of the Pharmatech Model Laboratory - Biotech Unit at the Budapest University of Technology and Economics.
Dr. Ballagi moved to Sweden shortly after completing his degree in bioengineering. There he worked in the field of the diagnosis and molecular evolution of veterinary viruses at the Swedish Veterinary Institute. He received his PhD for his research on application of PCR for virus detection and analysis of viral outbreaks. Later he moved on to fermentation technology of recombinant microorganisms at the University of Uppsala. After almost 20 years in Sweden he returned to Hungary in 2006 and joined Gedeon Richter Plc. to lead the technology development for biosimilar medicine production using bacteria (E.coli) as well as mammalian (CHO) cells.
In 2014 he formed the Biotechnology unit in the newly established Pharmatech Model Laboratory (PML) at the Budapest University of Technology and Economics, where he is also holding an Honorary Professorship. The PML, which is supported by Gedeon Richter Plc. is working on future technologies for medicine production and bioreactor-based stem cell propagation.
Lenka Francišković, Head of Processes and Products Quality, Belupo Pharmaceuticals Croatia
Lenka is a Pharmaceutical Professional with a unique combination of pharmaceutical management experience and exceptional knowledge in the areas of the New Product Evaluation, Laboratory Operations, Pharmaceutical Analysis and Project Management. She has an extensive experience in pharmaceutical industry in Research and Development, Regulatory Affairs, Quality Assurance and Quality Control Environment as well as profound knowledge of TPB and FDA, EU and Croatian regulatory submission requirements. Strong knowledge of GMP, GLP, ICH guidelines and Pharmacopoeia is inevitable part of Lenkas‘ professional skills. Lenka is currently Head of Processes and Products Quality for Belupo Pharmaceuticals Croatia. Prior to this work, she worked in several positions at Apotex Inc. Toronto, Ontario and Genpharm Inc. (now Milan Pharmaceuticals) in Etobicoke, Ontario. Lenka has published several publications, is member of Pharmaceutical Sciences Group, Toronto and Croatian Association for Quality.
Grzegorz Brzoskowski, Regional Security Director CEE, SANOFI CESD
Grzegorz Brzoskowski started his career at the National Police in Poland. Between 2007 and 2012 he was working as the Senior Security Partner at Genzyme Europe, Middle East and Africa (EMEA) and since 2012 Grzegorz Brzoskowski is in his current position as Regional Security Director Central East Europe at SANOFI responsible for 17 countries.
Dr. Erik Bogsch, Head of the Biotechnology R&D Division, Gedeon Richter
Dr. Erik Bogsch is the Head of the Biotechnology R&D Division at Gedeon Richter Plc. He is responsible for leading the R&D effort in the development of GR's biosimilar pipeline. Gedeon Richter Plc. is engaged in the development and manufacture of both bacterial cell fermentation based and mammalian cell fermentation based biosimilar products. GR has R&D, analytical & manufacturing capabilities in multiple locations in Hungary & Germany.
Dr. Bogsch, a Hungarian national, has a Natural Sciences degree from the University of Cambridge and a PhD in cell biology from the University of Warwick. Following a brief postdoctoral academic research career, he worked in the food industry for many years in R&D, Quality & Manufacturing roles in the UK, Hungary & Germany. He joined Gedeon Richter Plc. in 2012, as commissioning lead for GR's biotechnology factory in Debrecen, Hungary, before moving into his current role.
Dr. Zsolt Holló, Head of the Center of Biological Business Development and Technology, EGIS
Dr. Holló is medical doctor by training, obtained his PhD in cellular physiology at Semmelweis University (Budapest) and MBA degree at the Budapest University of Technology and Economics. Dr. Holló has over 10 years experience in biotechnology. Currently he is Head of the Biological Business Development and Technology Center at EGIS Pharmaceuticals Plc. His major responsibilities include biosimilar product-candidate evaluations; the implementation of biosimilar product related manufacturing and analytical technologies, quality control, management of technology transfers; developing partnerships in these areas. Prior to this position he was Chief Operations Officer at Solvo Biotechnology. He has spent more than 5 years in molecular diagnostics, in various positions from laboratory head to CEO. He has worked in the Netherlands Cancer Institute as an EMBO postdoctoral fellowship holder. Dr. Hollo has several publications and patents in cellular signalling, multidrug resistance and molecular diagnostics.